www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES
PANDEMIC PREPAREDNESS FOR BUSINESSES
COMMUNICATIONS MANAGEMENT
|
High demand items. Secure yours now. (Warning: Please note we are finding it increasingly difficult to find suppliers for these items)
Tamiflu for your staff and families Don’t rely on Government and hospital supplies. There won't be enough. Secure your order here. Relenza - The Tamiflu alternative Evidence is emerging of Tamiflu resistent pandemic flu strains. Hedge your bets and get Relenza here. Alpha Pro Tech N-95 Face Masks Manufacturers can't keep up as the cheap ones don't work. Get your N-95s here. |
|
FREE Influenza Pandemic Preparedness email eCourse. Get Your Certificate! Join our free pandemic preparedness and planning email eCourse program. Leave your name and email and we’ll take you, one step at a time, through your pandemic preparedness activities, plus give you TWO eBooks on pandemic planning and response for the home. Get a certificate too! To learn more and enroll yourself please click here. |
COMMUNICATIONS MANAGEMENT
13.1
Good communications management is critical to
business operations. From a practical standpoint, here are several initiatives
which should be considered:
13.1.1
Enabling staff to work from home. This is no
doubt the single most prolific initiative any Company can take to ensure staff
can continue to operate, regardless of whether they are staying at home to
protect themselves from infection, whether they are caring for others, or
whether they are well again after infection but are still quarantined and
unable to return to the office.
13.1.2
This initiative is also the most controversial
as most employers prefer staff to come to work as there are few controls
employers have over employees when they working from home.
13.1.3
Regardless, the arguments for working from home
outweigh the arguments against it, particularly in times of crisis when the
employee is unlikely to come to work anyway.
13.1.4
Do a risk assessment to identify staff who are critical to business operations.
Some of those require a physical presence in the office and some do not. Those
who are critical but do not require a physical presence should be equipped to
work from home and trained to use the equipment.
13.1.5
Staff working from home will require electronic
access to email, websites, files, programmes and other communications so that they may continue seamlessly
with their work.
13.1.6
Divert landline calls and messages.
Callers need not even know their call has been diverted from an office number
to a home number then back to an office number.
13.1.7
Install phone equipment which allows for communications
to be diverted, or if current communications equipment already includes this function, ensure
all staff are re-briefed on how the equipment operates. Consider re-fresher
training by the equipment provider.
Meetings should be held using conference calling equipment. Conference calling equipment is not expensive and can handle a large number of participants. Using a computer to make conference calls, international and local is becoing very common and there are many free and paid for products to choose from.
Conference calls for both local and international should be encouraged now so people are more comfortable and ready trained when the need becomes serious.
13.1.8
Install two-way videoconferencing or use conference calling services for those
who's job requires visual communications. Consider offering (for free) to
install videoconferencing equipment in top client offices so that your Company
representative can communicate visually with your client's representative.
Consider the same for critical suppliers.
13.1.9
As with any remote system access, ensure system
security protocols are in place and that systems are robust and scaleable to
handle the additional workload when remote working initiatives are called upon.
13.1.10
Consider enlisting the assistance of outsourced
IT professionals if there is no internal department responsible.
13.2
On more general communications management issues, it is
strongly recommended that employers should discuss this possibility of business
closure with their staff, staff representatives and contractors as part of
their preparedness planning. This discussion should include identifying whether
services can be delivered outside of the workplace in a way that does not pose
any health and safety risk, and implementing methods of communicating workplace
closure to employees.
13.3
In the event that the employer decides, or is
required to, suspend business during a pandemic, it is important that the
employment conditions during the business suspension are discussed with, and
made clear to, employees. Those discussions may include, for example, the use
of annual leave.
13.4
Contractors for services will be subject to
their contracts, and contract law generally.
13.5
If a workplace or business stays open during a
pandemic, employment relations legislation will continue to apply according to
the circumstances.
13.6
Keep communications Open and Frequent. In all
cases, it will be useful to discuss any likely impacts with employees, unions
and others that may be affected beforehand. Whatever agreement and
clarification can be achieved before a pandemic will prove a valuable
investment should the emergency occur.
13.7
It is likely there will be anxiety regarding a
pandemic and this is likely to contribute to increased work absence and/or
increased distress to staff. The suggested ways to manage this include:
13.7.1
Communicate the possibility of a pandemic - and
the Organisation’s preparedness to manage it - very early to staff.
13.7.2
Discuss with staff possible health and safety
issues, potential for stand down, and leave arrangements if they are ill or
need to look after those who are or who have been "shut out" of childcare and
school, etc.
13.7.3
Have the comprehensive communications management plan in place and
clearly communicated to staff. Ensure that communications management during the
pandemic is part of the plan. It will be important to have systems in place to
allow communications in a pandemic.
13.7.4
In activating the plan, provide clear, timely
and pro-active communications to staff, including how the organisation is
handling the situation.
13.7.5
Establish a "communications tree" to ensure efficient communicaion response is maintained.
13.8
Ensure the following policy guidelines are in
place for communicating with staff.
13.8.1
Make all communications timely and honest. Do
not 'cover up' as cover ups never work and they would serve only to erode
credibility and trust.
13.8.2
Make sure information comes from the
organisation first.
13.8.3
Simultaneous to all
13.8.4
Staff Awareness
13.8.5
Objective and Subjective assessments
13.8.6
Inform workforce simultaneously
13.8.7
Give bad news all at once
13.8.8
Provide opportunity for Questions
13.8.9
Regular updates and give time for next update
13.8.10
Methods of communications management
13.8.11
Draft notices in advance when possible
Don’t rely on Government and hospital supplies. There won't be enough. Get yours here now.
More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.
|

ONLINE'S OTHER TOPICS BELOW:
| 01/20/2010 09:00 PM |
| 1918 And 2009 H1N1 Flu Probably Not Spread By Birds |
|
The two strains of the H1N1 influenza virus responsible for the 1918 and 2009 global flu pandemics do not cause disease in birds. The results of the study, published in the February issue of the Journal of General Virology, also show it is unlikely that birds played a role in the spread of the H1N1 virus in these pandemics...
|
| 01/14/2010 05:00 PM |
| New Research Findings Can Improve Avian Flu Surveillance Programs |
|
Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research...
|
| 01/08/2010 06:00 PM |
| NexBio Initiates Phase II Trial Of DAS181 (Fludase(R)) For Treatment Of Influenza, Including Pandemic Influenza A(H1N1) |
|
NexBio, Inc. announced the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection. DAS181 is an investigational host-targeted drug candidate that blocks entry of influenza virus into cells of the respiratory tract...
|
| 01/07/2010 08:00 PM |
| Also In Global Health News: ART Access In Zimbabwe; Indonesia Bird Flu Deaths; Kenya Floods; Solomon Island Tsunami |
|
Zimbabwe Wants To Boost Access To ART By End Of 2010, Health Minister Says Zimbabwe's government plans work with international organizations to increase the number of people receiving anti-retroviral therapy (ART) to 300,000 by the end of the year, up from the 180,000 who currently get the drugs, Henry Madzorera, the country's health minister, said on Tues...
|
| 12/25/2009 04:00 PM |
| Compound Found To Safely Counter Deadly Bird Flu |
|
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public-health officials awake at night. Now, however, a study published this week (Dec...
|
| 12/22/2009 06:00 PM |
| Compound Found To Safely Counter Deadly Bird Flu |
|
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public health officials awake at night. Now, however, a study published this week (Dec...
|
| 12/22/2009 05:00 PM |
| Medicago Reports Positive Phase I Results For Its Avian Flu Pandemic Vaccine |
|
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine")...
|
| 12/07/2009 06:00 PM |
| 'Rational Drug Design' Identifies Fragments Of FDA-Approved Drugs Relevant To Emerging Viruses |
|
A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a present...
|
| 12/04/2009 07:00 PM |
| Transplant Infectious Disease Experts Provide Pandemic Guidance |
|
Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic...
|
| 11/17/2009 04:00 PM |
| Scientists Put Interactive Flu Tracking At Public's Fingertips |
|
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say...
|
| 11/02/2009 04:00 PM |
| Potential Downside Of Yearly Influenza Vaccination For Children |
|
An article published Online First and in the December edition of The Lancet Infectious Diseases discusses the benefits and disadvantages of vaccination for children against seasonal flu. It reports that infection with "seasonal" influenza A could in fact benefit children by giving them improved immunity against pandemic strains such as the current swine flu H1N1 strain...
|
| 10/26/2009 07:00 PM |
| News From The Journals Of The American Society For Microbiology |
|
Genes May Determine Susceptibility to H5N1 Avian Influenza A Virus Infection A new study found genetic variations in mice affect their susceptibility to and severity of H5N1 avian influenza A virus infection suggesting that humans who contract the virus may be genetically predisposed. The researchers from St...
|
| 10/22/2009 04:00 PM |
| Rice, UT-Austin Team Wins Stimulus Funds To Study Influenza A |
|
Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu...
|
| 10/15/2009 09:00 PM |
| Previous Flu Viruses Provided Some Immunity To Current Swine Flu, Study Shows |
|
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years...
|
| 10/14/2009 05:00 PM |
| ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat |
|
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist...
|
| 10/09/2009 05:00 PM |
| Protecting Humans And Animals From Diseases In Wildlife |
|
Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans...
|
| 10/06/2009 09:00 PM |
| News From Annals Of Internal Medicine, October 6, 2009 |
|
Early Releases: 1. Earlier H1N1 Vaccination Prevents More Deaths, Saves Health Care Costs A vaccine for H1N1 influenza is anticipated to become available this fall. With the amount and timing of vaccine release still in question, policy makers struggle to set priorities regarding who should be vaccinated when...
|
| 10/02/2009 06:00 PM |
| Medicago Begins Human Clinical Testing With Its Avian Flu Pandemic Vaccine |
|
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has initiated a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment is ongoing and vaccination has commenced...
|
| 08/28/2009 07:00 PM |
| H1N1 Flu In Turkeys May Spread |
|
The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today. Chilean authorities reported on 20 August that the pandemic H1N1/2009 virus was present in turkeys in two farms near the seaport of Valparaiso, Chile...
|
| 08/28/2009 06:00 PM |
| Lakewood-Amedex Inc. To Develop Broad Spectrum Influenza Drug To Include H1N1 And H5N1 Type A Strains |
|
Lakewood-Amedex Inc...
|









